Baker McKenzie advised EQT Life Sciences on the deal. EQT Life Sciences successfully closed a EUR 128 million (USD 138.8 million) Series B2 financing of Tubulis GmbH....
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised SIG-i Capital on the deal. SIG-i Capital completed the financing of FLABEG Group. SIG-i Capital is a private credit investment manager which made a...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised Ariceum Therapeutics (Ariceum) on the transaction. Ariceum Therapeutics (Ariceum) successfully completed a Series A extension financing, raising a further EUR 22.75 million, following the...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised Seamless Therapeutics GmbH on the deal. Seamless Therapeutics GmbH executed the closing of a $12.5 million Seed Financing, a university carve-out including equity...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised Ariceum Therapeutics on the deal. Ariceum Therapeutics (Ariceum) completed a EUR 25 million Series A financing round, co-led by EQT Life Sciences (formerly LSP)...
You must be a Standard 1 Year member to access this content.
CMS advised Tubulis on the deal, Baker McKenzie advised Andera Partners, Evotec and Fund+ on the deal. Biotech company Tubulis has successfully completed a Series B...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised Allecra Therapeutics on the deal. Allecra Therapeutics signed an exclusive licensing agreement with Advanz Pharma Corp. Limited, a specialty pharmaceutical company with a strategic...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised Modag GmbH on the deal. Blomstein advised Teva Pharmaceutical Industries Limited. MODAG GmbH signed a collaboration agreement with Teva Pharmaceutical Industries Ltd. on the exclusive...
You must be a Standard 1 Year member to access this content.
